Диссертация (1154725), страница 13
Текст из файла (страница 13)
doi: 10.1177/1060028017725763. [Epub ahead of print]68.Chakko S. Clinical, radiographic, and hemodynamic correlations in chroniccongestive heart failure: conflicting results may lead to inappropriate care. /Chakko S., Woska D., Marinez H. et al. // Am J Med. –1991. –vol.90. –p.
353–359.69.Chaudhry SI. Patterns of weight change preceding hospitalization for heartfailure / Chaudhry SI, Wang Y, Concato J, Gill TM, Krumholz HM // Circulation.–2007. –vool.116. –p.1549–1554.70.Cohen-Solal A. State of the art: using natriuretic peptide levels in clinicalpractice. / Cohen-Solal A, Dahlstrom U, DeMaria A, Di Somma S, Filippatos GS,Fonarow GC, Jourdain P, Komajda M, Liu PP, McDonagh T, McDonald K,Mebazaa A, Nieminen MS, Peacock WF, Tubaro M, Valle R, Vanderhyden M,Yancy CW, Zannad F, Braunwald E. // Eur J Heart Fail –2008.
–vol.10–p.824 –839.71.Cooper LB. Hemodynamic predictors of heart failure morbidity andmortality: fluid or flow? / Cooper LB, Mentz RJ, Stevens SR, Felker GM,Lombardi C, Metra M, et al. // J Card Fail. –2015 [Epub ahead of print].72.Cooper, L.B. The Impact of Worsening Heart Failure in the United States /L.B.
Cooper, A.D. DeVore, G.M. Felker // Heart Failure Clin. – 2015. – vol. 11. –p.603– 614.9673.Cotter G. Fluid overload in acute heart failure–re-distribution and othermechanisms beyond fluid accumulation / Cotter G, Metra M, Milo-Cotter O et al(2008). // Eur J Heart Fail –vol.10. –p.165–169.74.Creemers E.E. Molecular mechanisms that control interstitial fibrosis in thepressure-overloaded heart / Creemers E.E., Pinto Y.M. // Cardiovasc Res.
–2011. –vol. 89. –p. 265-72.75.De Berardinis B1. Usefulness of combining galectin-3 and BIVAassessments in predicting short- and long-term events in patients admitted for acuteheart failure. / De Berardinis B1, Magrini L1, Zampini G1, Zancla B1, Salerno G2,Cardelli P2, Di Stasio E3, Gaggin HK4, Belcher A4, Parry BA5, Nagurney JT5,Januzzi JL Jr4, Di Somma S1. // Biomed Res Int. –2014. –vol.44. –p.91-98. doi:10.1155/2014/983098.
Epub 2014 Jun 30.76.De Vecchis R. An Admission-to-Discharge BNP Increase Is a Predictor ofSix-Month All-Cause Death in ADHF Patients: Inferences from MultivariateAnalysis Including Admission BNP and Various Clinical Measures of Congestion./ De Vecchis R, Ariano C, Baldi C. // J Clin Med. –2016 Nov. –vol.10. –p.5(11).pii: E99.77.De Vecchis R. Change of Serum BNP Between Admission and DischargeAfter Acute Decompensated Heart Failure Is a Better Predictor of 6-Month AllCause Mortality Than the Single BNP Value Determined at Admission. / DeVecchis R, Ariano C, Giandomenico G, Di Maio M, Baldi C.
J // Clin Med Res. –2016.Oct. –vol.8(10). –p.737-42. doi: 10.14740/jocmr2691w. Epub 2016 Aug 30.78.Dharmarajan, K. et al. Diagnoses and timing of 30‐day readmissions afterhospitalization for heart failure, acute myocardial infarction, or pneumonia. JAMA–309, –p.355–363 (2013).79.Drazner MH.
Prognostic importance of elevated jugular venous pressure anda third heart sound in patients with heart failure. / Drazner MH, Rame JE,Stevenson LW, Dries DL. // N Engl J Med. –2001. –vol.345. –p.574–5819780.ESC Guidelines for the diagnosis and treatment of acute and chronic heartfailure –2016, European Heart Journal – doi:10.1093/eurheartj/ehw12881.Fudim, M. Role of Volume Redistribution in the Congestion of HeartFailure. / Adrian F. Hernandez, MD, G. Michael Felker, MD // J Am Heart Assoc.–2017. –vol.
6(8). –p. e006817.82.Fallick C. Sympathetically mediated changes in capacitance redistribution ofthe venous reservoir as a cause of decompensation / Fallick C, Sobotka PA, DunlapME..//CircHeartFail.–2011.–vol.4.–p.669–675.doi:10.1161/CIRCHEARTFAILURE.111.961789.83.Felker GM. The Valsalva maneuver: a edside „ iomarker‟ for heart failure./ Felker GM, Cuculich PS, Gheorghiade M. The Valsalva maneuver: a bedside„ iomarker‟ for heart failure.
// Am J Med –2006. –vol.119. –p.117 – 122.84.Fonarow GC. Admission B-type natriuretic peptide levels and in-hospitalmortality in acute decompensated heart failure / Fonarow GC, Peacock WF,Phillips CO, Givertz MM, Lopatin M. J // Am Coll Cardiol –2007. –vol.49. –p.1943 – 1950.75.85.From AM. Bedside assessment of cardiac hemodynamics: the impact ofnoninvasive testing and examiner experience / From AM, Lam CS, Pitta SR.Bedside assessment of cardiac hemodynamics: the impact of noninvasive testingand examiner experience. // Am J Med. –2011 –vol.124(11). –p.1051-7.86.Gheorghiade M. Acute heart failure syndromes: current state andframework for future research / Gheorghiade M, Zannad F, Sopko G et al (2005) //Circulation –112.
–p.3958–396887.Gheorghiade M. Assessing and grading congestion in acute heart failure: ascientific statement from the Acute Heart Failure Committee of the Heart FailureAssociation of the European Society of Cardiology and endorsed by the EuropeanSociety of Intensive Care Medicine. / Gheorghiade M., Follath F., Ponikowski P. etal. // Eur J Heart Fail. –2010. –vol.12. –p.423–433.9888.Gheorghiade M. Effects of tolvaptan, a vasopressin antagonist, in patientshospitalized with worsening heart failure: a randomized controlled trial /Gheorghiade M, Gattis WA, O‟Connor CM, Adams KF Jr, Elkayam U,Barbagelata A, Ghali JK, Benza RL, McGrew FA, Klapholz M, Ouyang J, OrlandiC.// JAMA –2004. –vol.291.
–p. 1963 – 1971.89.Gheorghiade, M. & Peterson, E. D. Improving postdischarge outcomes inpatients hospitalized for acute heart failure syndromes. // JAMA –305, –p.2456–2457 (2011).90.Gheorghiade, M. Acute Heart Failure Syndromes / M. Gheorghiade, P.S.Pang // J Am Coll Cardiol. – 2009.
–vol.53. – p.557 – 573.91.Gil Martínez P1. Amino-terminal pro-B-type natriuretic peptide, inferiorvena cava ultrasound, and biolectrical impedance analysis for the diagnosis ofacute decompensated CHF. / Gil Martínez P1, Mesado Martínez D2, Cur eloGarcía J3, Cadiñanos Loidi J4. // Am J Emerg Med. –2016. –vol.34(9).
–p.181722. doi: 10.1016/j.ajem.2016.06.043. Epub 2016 Jun 14.92.Greenberg, B. Novel Therapies for Heart Failure – Where Do They Stand?// Circ J. – 2016. – vol.80. – p.1882–1891.93.Guyton A.C. Textbook of medical physiology (8th Edition). / Philadelphia,PA: // WB Saunders, –1991, –pp 799.94.Jobs A. Inferior vena cava diameter in acute decompensated heart failure aspredictor of all-cause mortality / Jo s A, Brünjes K, Katalinic A, Ba aev V, DeschS, Reppel M, Thiele H. // Heart Vessels.–2017 –vol.32(7). –p.856-864.
doi:10.1007/s00380-017-0944-0. Epub 2017 Jan 23.95.John, R. Acute Decompensated Heart Failure / R. John, J.R. Teerlink, K.Alburikan, M. Metra and Jo E. Rodgers // Update Current Cardiology Reviews. –2015. – vol.11. – p. 53-62.96.Kabach M. Ultrafiltration versus intravenous loop diuretics in patients withacute decompensated heart failure: a meta-analysis of clinical trials / Kabach M,Alkhawam H, Shah S, Joseph G, Donath EM, Moss N, Rosenstein RS, Chait R. //99ActaCardiol.–2017.–vol.72(2).–p.132-141.doi:10.1080/00015385.2017.1291195. Epub 2017 Feb 28.97.Kono T. Left ventricular shape as a determinant of functional mitralregurgitation in patients with severe heart failure secondary to either coronaryartery disease or idiopathic dilated cardio- myopathy / Kono T, Sabbah HN, SteinPD, Brymer JF, Khaja F. // Am J Cardiol –1991.
–vol.68. –p.355–359.98.Lala A. Relief and Recurrence of Congestion During and AfterHospitalization for Acute Heart Failure: Insights From Diuretic OptimizationStrategy Evaluation in Acute Decompensated Heart Failure (DOSE-AHF) andCardiorenal Rescue Study in Acute Decompensated Heart Failure (CARESS-HF) /Lala A, McNulty SE, Mentz RJ, et al.
// Circ Heart Fail. – 2015. –vol.8(4). –p.741748.99.Leier CV . Nuggets, pearls, and vignettes of master heart failure clinicians.Part 2-the physical examination / Leier CV, Young JB, Levine TB, Pina I. //Congest Heart Fail –2001. –vol.7. –p.297 – 308.100.Lewin J . Clinical deterioration in established heart failure: what is the valueof BNP and weight gain in aiding diagnosis? / Lewin J, Ledwidge M, O‟LoughlinC, McNally C, McDonald K. // Eur J Heart Fail. –2005. –vol.7.
–p.953–957.101.Lucas C. Freedom from congestion predicts good survival despite previousclass IV symptoms of heart failure / Lucas C, Johnson W, Hamilton MA, FonarowGC, Woo MA, Flavell CM, Creaser JA, Stevenson LW. // Am Heart J –2000. –vol.140. –p.840 – 847.102.Mahdyoon H. Radiographic pulmonary congestion in end-stage congestiveheart failure / Mahdyoon H., Klein R., Eyler W. et al. // Am J Cardiol –1989. –vol.63. –p. 625–627.103.Marat Fudim, MD. Role of Volume Redistribution in the Congestion ofHeart Failure / Marat Fudim, MD; Adrian F.
Hernandez, MD; G. Michael Felker,MD. // J Am Heart Assoc. –2017. –vol.6. –p.e006817100104.Marini E . Efficacy of specific bioelectrical impedance vector analysis(BIVA) for assessing body composition in the elderly / Marini E, Sergi G, SuccaV, Saragat B, Sarti S, Coin A et al. // J Nutr Health Aging –2013–vol.17. –p.515–521.105. Martens P.
Current Approach to Decongestive Therapy in Acute HeartFailure. Martens P, Nijst P, Mullens W. Curr Heart Fail Rep. 2015 Dec;12(6):36778. doi: 10.1007/s11897-015-0273-5. Review.106.Mebazaa, A. Recommendations on pre-hospital and early hospitalmanagement of acute heart failure: a consensus paper from the Heart FailureAssociation of the European Society of Cardiology, the European Society ofEmergency Medicine and the Society of Academic Emergency Medicine – shortversion / A. Mebazaa, M.B. Yilmaz, P. Levy, et al.
// Eur Heart J. – 2015. – vol.36. – p. 1958–1966.107.Mentz, R.J. Noncardiac Comorbidities and Acute Heart Failure Patients /R.J. Mentz, G.Felker // Heart Fail Clin. -2013. – vol. 9(3). - p. 359–vii.108.Mentz, R.J. Pathophysiology and clinical evaluation of acute heart failure /R.J. Mentz, C.M. O'Connor // Nat Rev Cardiol. – 2016. – vol.13(1).
–p.28-35.109. Miller WL1. Fluid Volume Overload and Congestion in Heart Failure: Timeto Reconsider Pathophysiology and How Volume Is Assessed / Miller WL1. //Circ Heart Fail. –2016. –vol.9(8). –p.e002922.110.Mullens, W. Prompt Reduction in Intra-Abdominal Pressure FollowingLarge-Volume Mechanical Fluid Removal Improves Renal Insufficiency inRefractory Decompensated Heart Failure / W. Mullens, Z. Abrahams, G. Francis,D.
Taylor, R. Starling and W. Tang // Journal of Cardiac Failure. – 2008. –vol.14(6). – p. 508-514.111.Greene SJ1. The vulnerable phase after hospitalization for heart failure /Greene SJ1, Fonarow GC2, Vaduganathan M3, Khan SS4, Butler J5, GheorghiadeM1.//NatRevCardiol.–2015.10.1038/nrcardio.2015.14. Epub 2015 Feb 10.–vol12(4).–p.220-9.doi:101112.Negi S. Prognostic implication of physical signs of congestion in acute heartfailure patients and its association with steady-state biomarker levels / Negi S,Sawano M, Kohsaka S, Inohara T. // PLoS One. – 2014.6. –vol.9(5). –p.
e96325.113.Nohria A. Clinical assessment identifies hemodynamic profiles that predictoutcomes in patients admitted with heart failure / Nohria A, Tsang SW, Fang JC,Lewis EF, Jarcho JA, Mudge GH, Stevenson LW. // J Am Coll Cardiol –2003. –vol.41. –p.1797–1804.114. Noman A.Effect of high-dose allopurinol on exercise in patients withchronic stable angina: a randomised, placebo controlled crossover trial / NomanA., Ang D.S., Ogston S., Lang C.C., Struthers A.D. // Lancet. –2010.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
